Medical Weight Loss Central New York

Medical Weight Loss Central New York operates from Manlius, NY, under the clinical direction of Dr. Wendy Scinta, MD, MS, a board-certified obesity medicine physician who brings specialized training in the medical management of weight and metabolic conditions. The practice focuses exclusively on evidence-based weight loss interventions, combining pharmaceutical therapies with comprehensive metabolic assessment and ongoing medical supervision. Dr. Scinta's dual credentials in medicine and medical science inform a clinical approach that addresses weight loss as a complex medical condition requiring individualized treatment protocols rather than one-size-fits-all solutions. Patients receive in-person consultations that include detailed metabolic evaluation, body composition analysis, and assessment of hormonal factors that influence weight regulation.

The clinic's pharmaceutical weight loss protocols center on GLP-1 receptor agonist therapies, specifically semaglutide and tirzepatide, both FDA-approved medications that work through glucagon-like peptide pathways to regulate appetite, slow gastric emptying, and improve glycemic control. Semaglutide is administered as a once-weekly subcutaneous injection, with dosing titrated based on individual tolerance and response, while tirzepatide offers dual GIP/GLP-1 receptor activation for patients who may benefit from enhanced metabolic effects. Dr. Scinta prescribes these medications as part of structured treatment plans that include regular monitoring of cardiovascular markers, liver function, and metabolic parameters. The practice does not offer these medications as standalone prescriptions but integrates them into comprehensive medical weight loss programs that address nutrition, physical activity capacity, and behavioral factors contributing to weight gain.

Hormone therapy represents a secondary treatment focus at Medical Weight Loss Central New York, addressing thyroid dysfunction, insulin resistance, and sex hormone imbalances that frequently complicate weight management efforts. Dr. Scinta evaluates patients for conditions such as hypothyroidism, polycystic ovary syndrome, and age-related hormonal changes that affect metabolism and body composition. Hormone optimization is approached through laboratory assessment and targeted replacement or modulation therapies designed to restore physiologic balance rather than supraphysiologic enhancement. This integrative approach recognizes that successful weight loss often requires addressing underlying endocrine dysfunction that creates metabolic resistance to dietary and lifestyle interventions alone.

Patients beginning treatment at the Manlius clinic undergo an initial consultation that includes comprehensive medical history review, physical examination, and laboratory testing to establish baseline metabolic function and identify contraindications to specific therapies. Dr. Scinta develops individualized treatment protocols based on each patient's medical history, current medications, weight loss goals, and metabolic profile. Follow-up visits occur at regular intervals determined by the treatment plan, typically every two to four weeks during the initial titration phase of GLP-1 therapy, with ongoing monitoring to assess treatment response, manage side effects, and adjust protocols as needed. The practice emphasizes medical supervision throughout the weight loss process, with Dr. Scinta available to address concerns about medication tolerance, plateau periods, or complications that may arise during treatment.

Medical Weight Loss Central New York serves patients throughout the Central New York region from its Manlius location, requiring in-person attendance for consultations and follow-up visits. This in-clinic model allows for direct physical assessment, real-time problem-solving, and the physician-patient relationship that Dr. Scinta considers essential to successful long-term weight management. The practice does not currently offer telehealth services, reflecting a clinical philosophy that prioritizes hands-on medical evaluation and the accountability that comes with regular in-person visits. Patients should expect a medically rigorous approach that treats obesity as a chronic disease requiring ongoing management rather than a short-term intervention, with treatment plans designed for sustained results through continued medical oversight and protocol adjustments based on individual response patterns.